Navigation Links
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Date:12/16/2013

LAVAL, Quebec and HAYWARD, Calif., Dec. 16, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Solta Medical, Inc. (NASDAQ: SLTM) for $2.92 per share in cash, which represents a 40% premium to Solta's closing share price on December 13, 2013, the last trading day prior to announcement, or a transaction value of approximately $250 million.  The transaction is expected to close in the first quarter of 2014 and Valeant expects the transaction, once completed, to be immediately accretive to Valeant's cash earnings per share. 

Solta designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications.  Solta's products include the Thermage CPT system that provides non-invasive treatment options using radiofrequency energy for skin tightening, the Fraxel repair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, the Clear + Brilliant system to improve skin texture and help prevent the signs of aging skin, and the Liposonix system that destroys unwanted fat cells resulting in waist circumference reduction.  Solta had total revenue of approximately $145 million in 2012. 

"The acquisition of Solta will bring tremendous value to Valeant's current aesthetic portfolio and together with our previous acquisitions, will create the broadest aesthetic portfolio in the industry," stated J. Michael Pearson, Chairman and Chief Executive Officer of Valeant.  "Solta's leading aesthetic devices are a natural fit with Valeant's facial i
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
(Date:7/29/2014)... 29, 2014  Drug development for hepatitis C ... rates and the intense need for curative therapy ... is underway as the market moves away from ... easily-tolerated, interferon-free oral therapies. Logo ... mega blockbuster Sovaldi is the first of these ...
(Date:7/29/2014)... RESEARCH TRIANGLE PARK, N.C. , July 29, ... focused on cloud-based drug design and development, announced ... I grant from the National Science Foundation Small ... is valued at $150,000. Cloud ... accelerates the development process by implementing new, innovative ...
Breaking Medicine Technology:Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000 2
... (NASDAQ: SVA ), a leading provider of biopharmaceutical ... Lee as a director to the Board of the Company ... who resigned from the Board due to personal reasons. ... a leading growth capital fund focused on China and India. ...
... The Neuroblastoma and Medulloblastoma Translational Research Consortium ... genomic-based clinical trial to treat and study pediatric ... The 11-member NMTRC, housed at Van ... of pediatric cancer clinical trial sites that includes ...
Cached Medicine Technology:Sinovac Appoints Kenneth Lee to Board of Directors 2Consortium Opens Landmark Personalized Medicine Children's Cancer Trial 2
(Date:7/29/2014)... California (PRWEB) July 29, 2014 A ... Sciences Professor Doug Ethell, PhD, has developed a blood ... earlier detection and the development of Alzheimer’s disease interventions, ... “Alzheimer’s disease is a puzzle, and this study represents ... for us over the past couple of years,” Ethell ...
(Date:7/29/2014)... July 29, 2014 Most people want to ... younger and feel better about their appearance. There are ... too in Asheville, NC that can help them to look ... salon specializing in result oriented anti-aging procedures that are noninvasive ... problem so many have with cellulite. To accommodate, they ...
(Date:7/29/2014)... way to cure most cases of cancer is to ... approach, however, is that the surgeon may fail to ... , With a new technique, researchers at the University ... surgeons see the entire tumor in the patient, increasing ... on an injectable dye that accumulates in cancerous tissues ...
(Date:7/29/2014)... The report, “Heat Transfer Fluids Market by Type ... & Others), by Application (Oil & Gas, Chemical, CSP, ... & Forecasts to 2019” defines and segments the global ... of the global consumption in terms of volume and ... spread through 199 page sand in-depth TOC on"Heat Transfer ...
(Date:7/29/2014)... As testosterone treatment lawsuits ( http://www.injurybeacon.com/testosterone-androgel/lawsuit/ ... LLP notes that a new study is questioning the ... diabetes. The research, which was published online by The ... involved 88 men who suffered from Type 2 diabetes, ... symptoms and erectile dysfunction. Roughly half of the study ...
Breaking Medicine News(10 mins):Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2Health News:Supreme Skin Announces Plans for a Grand Re-opening for Their Noninvasive Anti Aging Microcurrent Face and Body Treatments In Asheville, NC 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 4Health News:As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics 2Health News:As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics 3Health News:As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics 4
... 12, 2008 ... , WHO/ WHAT: "Iron Andy" Holder, an Ironman Arizona competitor who was ... this Sunday,s triathlon to encourage others who have chronic ... their condition and to live without limits., ...
... Up to Promote New Appliance Line,s European, Style and Ingenious Features ... ... YORK, April 3, 2008 Known and admired for her,multi-tasking talents as ... Ripa for the North America launch of its new,premium kitchen appliance line ...
... screening, recommended by the Centers for Disease Control, ... critical to preventing still births and serious birth ... study published in the April issue of the ... statistics, when used to determine screening rates, may ...
... gap between stated and unstated feelings about Clinton, ... people feel more "insecure" than they are typically willing,to ... Company. In,addition, the "confidence" voters express about the U.S. ... surface and therefore does not appear to be,very deep., ...
... April 3, 2008 /PRNewswire/ - The GLOBAL ... service for,business executives in pharmaceutical and life ... and other industries,launches a Virtual Tour of ... COUNCIL service by visiting, http://www3.best-in-class.com/gr148.htm or ...
... The International Neuroinformatics Coordinating Facility (INCF) announces further ... the Neuroscience Peer Review Consortium (NPRC) initiative. The ... have agreed to accept manuscript reviews from other ... research articles. Currently, 27 journals have joined the ...
Cached Medicine News:Health News:Ironman Competitor with Diabetes Encourages Others to Live Without Limits; Competes in Ironman Arizona in Tempe 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 3Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 4Health News:Prenatal syphilis screening rates: Are they being accurately reported? 2Health News:Voting for Clinton Evokes Deep-Seated Feelings of Insecurity 2Health News:Global Benchmarking Council Launches New Virtual Tour of Research & Networking Service 2Health News:Neuroscience Peer Review Consortium announces increased journal participation 2
High-quality eyecare from the preferred name in diagnostic instruments....
Our 2.5v Streak Retinoscope Sets feature instruments with bright light, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Medicine Products: